Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019
ONSIW
ONSIW was delisted on the 3rd of December, 2018.
6 hedge funds and large institutions have $20K invested in Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.
14% less funds holding
Funds holding: 7 → 6 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
57% less capital invested
Capital invested by funds: $46K → $20K (-$26K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$10.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$1K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$143 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CAM
1
Cormorant Asset Management
Boston,
Massachusetts
| $9K | – | – | – |
|
|
PA
2
Perceptive Advisors
New York
| $6K | +$10.4K | +420,875 | New |
|
|
ACA
3
Avoro Capital Advisors
New York
| $3K | – | – | – |
|
|
MWNA
4
Marshall Wace North America
New York
| $1K | – | – | – |
|
|
PC
5
PointState Capital
New York
| $1K | – | – | – |
|
|
VF
6
Virtu Financial
New York
| – | -$1K | -13,755 | Closed |
|
|
7
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$143 | -5,776 | -36% |
|
ONSIW Hedge Fund Activity: Q3 2018 in Review
6 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 (ONSIW) for Q3 2018, worth a combined $20K — down 57% from $46K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ONSIW and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest buyer was Perceptive Advisors, opening a new position worth an estimated $10.4K. The largest seller was Virtu Financial, exiting entirely with an estimated $1K sold.
- 6 institutional investors held Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 (ONSIW) as of Q3 2018, down from 7 in Q2 2018.
- Funds reported $20K of Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 stock for Q3 2018, down 57% quarter-over-quarter.
- 1 fund opened new Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 positions in Q3 2018 and 2 closed out, a net change of -1 holder.
- The largest Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 buyer in Q3 2018 was Perceptive Advisors, an estimated $10.4K added.
- The largest Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 seller in Q3 2018 was Virtu Financial, an estimated $1K sold.
Based on aggregated 13F filings for Q3 2018.